Acadia Healthcare financials
$28.04+0.47%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.31B | $3.15B | $2.93B | $2.61B | $2.31B | $2.09B | $2.01B | $1.90B | $2.84B | $2.81B |
| Gross profit | $3.31B | $3.15B | $2.93B | $2.61B | $2.31B | $2.09B | $2.01B | $1.90B | $2.84B | $2.81B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $73.4M | $475.5M | $56.8M | $446.2M | $396.6M | $360.9M | $286.9M | $283.5M | $437.9M | $445.1M |
| Net income | -$1.10B | $255.6M | -$21.7M | $273.1M | $190.6M | -$672.1M | $108.9M | -$175.8M | $199.8M | $6.1M |
| Net margin | −33.3% | 8.1% | −0.7% | 10.5% | 8.2% | −32.2% | 5.4% | −9.2% | 7.0% | 0.2% |
| Diluted EPS | $-12.16 | $2.78 | $-0.24 | $2.98 | $2.10 | $-7.59 | $1.24 | $-2.01 | $2.30 | $0.07 |
| EBITDA | $577.2M | $671.9M | $645.4M | $564.0M | $503.3M | $460.9M | $402.0M | $385.9M | $580.9M | $580.2M |
| Operating cash flow | $131.9M | $129.7M | $462.3M | $380.6M | $374.5M | $658.8M | $332.9M | $414.1M | $399.6M | $361.5M |
| Free cash flow | -$439.9M | -$560.7M | $38.2M | $84.4M | $129.7M | $433.8M | $100.2M | $142.5M | $84.3M | $54.0M |
| Diluted shares | 90.7M | 92.1M | 90.9M | 91.6M | 90.8M | 88.6M | 87.8M | 87.4M | 87.1M | 86.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $133.2M | $76.3M | $100.1M | $97.6M | $133.8M | $378.7M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $2.50B | $1.96B | $1.37B | $1.39B | $1.50B | $3.12B |
| Total assets | $5.53B | $5.96B | $5.36B | $4.99B | $4.77B | $6.50B |
| Total liabilities | $3.39B | $2.77B | $2.47B | $2.09B | $2.19B | $4.54B |
| Shareholders' equity | $1.95B | $3.07B | $2.78B | $2.81B | $2.52B | $1.90B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology